Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-743 in Children With Rett Syndrome
NCT01822249Phase 2Completed
- Sponsor
- Bioelectron
- Start
- Jan 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatiquinone in Rett syndrome (RTT), sponsored by Bioelectron. Started Jan 2013; status: completed.
02
Drugs
vatiquinone
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT01822249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822249.